Clinical trial
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate…
NCT00197067 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197067 |
|---|---|
| Title | A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique. |
| Official title | A Bridging Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | RTS, S/AS02D and RTS, S/AS02A |
| Enrollment | 200 |
| Start date | Mar 15, 2004 |
| Primary completion | Apr 26, 2005 |
| Completion | Apr 26, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 27, 2019 |
| Countries | Mozambique |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: